...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Oman Journal of Ophthalmology >Short term outcome of Ahmed glaucoma valve implantation in management of refractory glaucoma in a tertiary hospital in Oman
【24h】

Short term outcome of Ahmed glaucoma valve implantation in management of refractory glaucoma in a tertiary hospital in Oman

机译：阿曼一家三级医院的Ahmed青光眼瓣膜植入术治疗难治性青光眼的近期结果

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background:We present outcomes of Ahmed Glaucoma Valve (AGV) implantation in treating refractory glaucoma in a tertiary hospital in Oman. Refractory glaucoma was defined as previously failed conventional glaucoma surgery and an uncontrolled intraocular pressure (IOP) of more than 21 mm Hg despite treatment with three topical and/or oral therapy.Materials and Methods:This historical cohort study was conducted in 2010. Details of medical and surgical treatment were recorded. Ophthalmologists examined eyes and performed glaucoma surgeries using AGV. The best corrected distant vision, IOP, and glaucoma medications were prospectively reviewed on 1st day, 1st, 6th, 12th week postoperatively, and at the last follow up.Result:Glaucoma specialists examined and treated 40 eyes with refractory glaucoma of 39 patients (20 males + 19 females). Neo-vascular glaucoma was present in 23 eyes. Vision before surgery was <3/60 in 21 eyes. At 12 weeks, one eye had vision better than 6/12, seven eyes had vision 6/18 to 6/60, and eight eyes had vision 6/60 to 3/60. Mean IOP was reduced from 42.9 (SD 16) to 14.2 (SD 8) and 19.1 (SD 7.8) mmHg at one and 12 weeks after surgery, respectively. At 12 weeks, five (12.5%) eyes had IOP controlled without medication. In 33 (77.5%) eyes, pressure was controlled by using one or two eye drops. The mean number of preoperative anti-glaucoma medications (2.38; SD 1.1) was reduced compared to the mean number of postoperative medications (1.92; SD 0.9) at 12 weeks.Conclusion:We succeeded in reducing visual disabilities and the number of anti-glaucoma medications used to treat refractory glaucoma by AGV surgery.
机译：背景：我们介绍了阿曼（Ahmed）青光眼瓣膜（AGV）植入在阿曼一家三级医院治疗难治性青光眼的结果。难治性青光眼定义为先前失败的常规青光眼手术，尽管进行了三种局部和/或口服治疗，但眼内压（IOP）仍超过21毫米汞柱。材料与方法：这项历史性队列研究于2010年进行。记录药物和手术治疗。眼科医生检查眼睛并使用AGV进行青光眼手术。在术后的第1天，第1天，第6周，第12周以及最后一次随访前瞻性地回顾了最佳的矫正远视，IOP和青光眼药物。结果：青光眼专家检查并治疗了40眼难治性青光眼39例（20眼）男+ 19女）。 23只眼出现新血管性青光眼。手术前的视力在21眼中小于3/60。在12周时，一只眼睛的视力优于6/12，七只眼睛的视力从6/18至6/60，八只眼睛的视力在6/60至3/60。术后1周和12周的平均眼压分别从42.9（SD 16）降至14.2（SD 8）和19.1（SD 7.8）mmHg。在第12周时，五只（12.5％）的眼睛在没有药物的情况下可以控制眼压。在33只（77.5％）的眼睛中，通过使用一或两滴眼药水来控制压力。与12周时的术后平均药物治疗次数（1.92; SD 0.9）相比，术前抗青光眼药物的平均使用量减少了（2.38; SD 1.1）。结论：我们成功减少了视力障碍和抗青光眼的使用数量通过AGV手术治疗难治性青光眼的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号